Pivotal Life Sciences — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments.
BiotechHealthtechMedical DevicesBoston, CH
Riad Sherif(Chief Executive Officer)in
Co-investorsBay City CapitalBrunnur Ventures GPVI PartnersBVCF
Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.
AI & Machine LearningData & InfrastructureDefense TechTel Aviv
Amiad Daniel(Executive Officer, Director)Matan Peled(Director)in
BoardDov Gatmon(Director)Patrick Poon(Director)Eden Shochat(Director)inThompson Hutton(Director)in
Co-investorsAlephFTV CapitalThompson Hutton, LLCJanus Henderson InvestorsQiming Venture PartnersQuan Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.